Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $829.2600 (-0.13%) ($829.2600 - $829.2600) on Fri. Apr. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 58 | Latest Price | $829.2600(-0.13%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(46%) DIA(35%) VYM(33%) IWD(32%) | Factors Impacting REGN price | REGN will decline at least -0.785% in a week (0% probabilities). VXX(-29%) VIXM(-22%) EDOC(-5%) UUP(-4%) TBT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $824.31(0.6%) | 10 Day Moving Average | $824.37(0.59%) | 20 Day Moving Average | $809.23(2.48%) | To recent high | -0.1% | To recent low | 15.8% | Market Cap | $87.925b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |